caffeine has been researched along with Recrudescence in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (21.43) | 18.7374 |
1990's | 8 (19.05) | 18.2507 |
2000's | 13 (30.95) | 29.6817 |
2010's | 10 (23.81) | 24.3611 |
2020's | 2 (4.76) | 2.80 |
Authors | Studies |
---|---|
Aylward, P; Bhatt, DL; Bonaca, MP; Dellborg, M; Furtado, RHM; Goto, S; Gurmu, Y; Isaza, D; Johanson, P; Kamensky, G; Magnani, G; Nicolau, JC; Steg, PG; Storey, RF; Venkateswaran, RV | 1 |
Han, MJ; Hwang, JH; Kim, SH; Shin, JH | 1 |
López-García, E; Rodríguez-Artalejo, F | 1 |
Chen, SL; Ennis, SS; Guo, H; Raman, L; Tambyah, PA; Tiong, HY | 1 |
Peerapen, P; Thongboonkerd, V | 1 |
Carroll, ME; Claxton, AB; Regier, PS; Zlebnik, NE | 1 |
Henesch, JA; Hoffman, RS; Laskowski, LK; Nelson, LS; Smith, SW | 1 |
Baños, I; Barajas, A; Del Cacho, N; Dolz, M; Huerta-Ramos, E; Núñez, C; Ochoa, S; Sánchez, B; Usall, J | 1 |
Dhillon, R; Tibrewal, P | 1 |
De Paoli, AG; Henderson-Smart, DJ | 1 |
Menkes, DB | 1 |
Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC | 1 |
Aloisio, A; Del Bianco, P; Di Monda, V; Fonzari, M; Grazioli, I; Nicolodi, M; Sicuteri, F; Uslenghi, C; Vecchiet, L | 1 |
Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW | 1 |
De La Corte, FD; Dranchak, PK; Ekenstedt, K; Gallant, EM; MacLeay, JM; McKenzie, EC; Mickelson, JR; Onan, GW; Valberg, SJ | 1 |
Colton, P; Poynter, B; Sacevich, T; Schreiber, M; Staab, R; Sutandar-Pinnock, K; Woodside, DB | 1 |
Cnattingius, S; George, L; Granath, F; Johansson, AL; Olander, B | 1 |
Hopkins, M; Malik, SN; Silberstein, SD; Young, WB | 1 |
Cerbo, R; Del Bene, E; Ferrari, A; Genco, S; Grazioli, I; Martelletti, P; Nappi, G; Pinessi, L; Sandrini, G; Sarchielli, P; Tamburro, P; Uslenghi, C; Zanchin, G | 1 |
Blin, MC; Couchard, M; De Gamarra, E; Dreyfus-Brisac, C; Flouvat, B; Moriette, G; Murat, I; Relier, JP | 1 |
Astasio-Arbiza, P; de Juanes-Pardo, JR; Domínguez-Rojas, V; Gordillo-Florencio, E; Ortega-Molina, P | 1 |
Beale, MD; Kellner, CH; Pritchett, JT | 1 |
Anaya Ordóñez, S; Matas Hoces, A | 1 |
Barnhart, WJ; Lehman, DA; Nestler, EJ; Self, DW | 1 |
Maizels, M | 1 |
Balog, EM; Gallant, EM; Lentz, LR; Mickelson, JR; Valberg, SJ | 1 |
Gallant, EM; Mickelson, JR; Valberg, SJ; Ward, TL | 1 |
Tobias, JD | 1 |
Ajioka, RS; Bergonia, HA; Bulaj, ZJ; Edwards, CQ; Franklin, MR; Griffen, LM; Guinee, DJ; Kushner, JP; Miller, KL; Phillips, JD | 1 |
Freeman, D; Randall, DB | 1 |
Bache, M; Bartel, F; Dunst, J; Meye, A; Pigorsch, S; Rath, FW; Schmidt, H; Taubert, H; Würl, P | 1 |
Mauskop, A | 1 |
Rudas, N; Tondo, L | 1 |
Bairam, A; Vert, P | 1 |
La Cascia, C; Mascarella, A; Migneco, G; Navetta, A; Tripi, S | 1 |
Bucher, HU; Duc, G | 1 |
Holstege, A | 1 |
Birkett, DJ; Cameron-Traub, E; James, JE; Lelo, A; Miners, JO; Paull, I | 1 |
Dzegede, S; Finlayson, B; Scheaffer, RL; Shuster, J; Sierakowski, R; Zoltek, J | 1 |
Friedman, AP | 1 |
4 review(s) available for caffeine and Recrudescence
Article | Year |
---|---|
Coffee Consumption and Cardiovascular Disease: A Condensed Review of Epidemiological Evidence and Mechanisms.
Topics: Aged; Blood Pressure; Caffeine; Cardiovascular Diseases; Coffee; Female; Humans; Hypertension; Male; Middle Aged; Recurrence; Risk Factors; Smoking | 2018 |
Caffeine in Kidney Stone Disease: Risk or Benefit?
Topics: Beverages; Caffeine; Carbonated Beverages; Coffee; Diet; Diuretics; Dose-Response Relationship, Drug; Energy Drinks; Humans; Kidney; Kidney Calculi; Prospective Studies; Recurrence; Retrospective Studies; Risk Factors; Tea | 2018 |
Prophylactic methylxanthine for prevention of apnoea in preterm infants.
Topics: Apnea; Bradycardia; Caffeine; Central Nervous System Stimulants; Humans; Hypoxia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Recurrence; Theophylline; Xanthines | 2010 |
[Effects of nicotine, alcohol and caffeine on the incidence, healing and recurrence rate of peptic ulcer].
Topics: Caffeine; Ethanol; Humans; Nicotine; Peptic Ulcer; Recurrence; Smoking; Wound Healing | 1987 |
7 trial(s) available for caffeine and Recrudescence
Article | Year |
---|---|
Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Topics: Aged; Aspirin; Beverages; Caffeine; Double-Blind Method; Dual Anti-Platelet Therapy; Dyspnea; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Secondary Prevention; Ticagrelor; Time Factors; Treatment Outcome | 2020 |
Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Drug Combinations; Female; Humans; Indomethacin; Male; Migraine Disorders; Prochlorperazine; Recurrence; Research Design; Serotonin Receptor Agonists; Sumatriptan; Suppositories; Treatment Outcome | 2003 |
Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, mu
Topics: Administration, Oral; Adolescent; Adult; Analgesics; Caffeine; Double-Blind Method; Drug Combinations; Female; Humans; Indomethacin; Male; Middle Aged; Migraine Disorders; Prochlorperazine; Recurrence; Sumatriptan; Treatment Outcome | 2007 |
The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants.
Topics: Apnea; Caffeine; Humans; Infant, Newborn; Infant, Premature, Diseases; Prospective Studies; Recurrence | 1981 |
[Sumatriptan in the treatment of acute migraine: its role in primary health care].
Topics: Acute Disease; Administration, Oral; Algorithms; Aspirin; Caffeine; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Humans; Injections, Subcutaneous; Metoclopramide; Migraine Disorders; Recurrence; Sumatriptan | 1994 |
A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group.
Topics: Administration, Oral; Adult; Aged; Caffeine; Double-Blind Method; Drug Combinations; Electrocardiography; Ergotamine; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Nausea; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Vomiting | 1991 |
Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial.
Topics: Blood Gas Monitoring, Transcutaneous; Bradycardia; Caffeine; Citrates; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hypoxia; Infant, Newborn; Infant, Premature, Diseases; Male; Random Allocation; Recurrence | 1988 |
31 other study(ies) available for caffeine and Recrudescence
Article | Year |
---|---|
Caffeine-induced hypokalemia: a case report.
Topics: Adult; Caffeine; Coffee; Diet Therapy; Diuretics; Drinking Behavior; Fluid Therapy; Humans; Hypokalemia; Male; Muscle Weakness; Osmolar Concentration; Paraplegia; Potassium; Recurrence; Treatment Outcome; Urinalysis | 2021 |
Premenopausal women with recurrent urinary tract infections have lower quality of life.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Caffeine; Coffee; Comorbidity; Constipation; Feeding Behavior; Female; Humans; Premenopause; Quality of Life; Recurrence; Risk Factors; Singapore; Surveys and Questionnaires; Urinary Tract Infections | 2018 |
Cocaine-, caffeine-, and stress-evoked cocaine reinstatement in high vs. low impulsive rats: treatment with allopregnanolone.
Topics: Animals; Behavior, Addictive; Caffeine; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Delay Discounting; Extinction, Psychological; Female; Impulsive Behavior; Pregnanolone; Rats; Rats, Inbred Strains; Recurrence; Self Administration; Yohimbine | 2014 |
Start me up! Recurrent ventricular tachydysrhythmias following intentional concentrated caffeine ingestion.
Topics: Adrenergic beta-Antagonists; Caffeine; Dietary Supplements; Electric Countershock; Electrocardiography; Female; Hemodynamics; Humans; Poisoning; Recovery of Function; Recurrence; Renal Dialysis; Severity of Illness Index; Suicide, Attempted; Tachycardia, Ventricular; Treatment Outcome; Young Adult | 2015 |
Differential effects of sex on substance use between first episode psychosis patients and healthy people.
Topics: Adolescent; Adult; Alcohol Drinking; Caffeine; Cannabis; Comorbidity; Female; Humans; Illicit Drugs; Male; Marijuana Abuse; Prevalence; Psychoses, Substance-Induced; Psychotic Disorders; Recurrence; Reference Values; Risk Factors; Sex Factors; Smoking; Spain; Substance-Related Disorders; Young Adult | 2016 |
Caffeine induced psychotic exacerbation.
Topics: Caffeine; Humans; Male; Middle Aged; Recurrence; Schizophrenia | 2011 |
Transient psychotic relapse temporally related to ingestion of an "energy drink".
Topics: Adult; Beverages; Caffeine; Central Nervous System Stimulants; Humans; Male; Psychoses, Substance-Induced; Recurrence | 2011 |
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Creatine Kinase; Dantrolene; Disseminated Intravascular Coagulation; Female; Genetic Variation; Hallucinogens; Haloperidol; Halothane; Humans; Multiple Organ Failure; N-Methyl-3,4-methylenedioxyamphetamine; Neuroleptic Malignant Syndrome; Recurrence; Rhabdomyolysis; Ryanodine Receptor Calcium Release Channel; Spectrum Analysis; Young Adult | 2012 |
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Macrophages; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mice, Knockout; Microglia; Multiple Sclerosis; Myelin Sheath; Phenotype; Receptor, Adenosine A1; Recurrence; RNA, Messenger; Severity of Illness Index; Spinal Cord; Up-Regulation | 2004 |
Inheritance of recurrent exertional rhabdomyolysis in thoroughbreds.
Topics: Anesthetics, Inhalation; Animals; Biopsy; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Female; Genes, Dominant; Halothane; Horse Diseases; Horses; Male; Muscle Contraction; Muscle, Skeletal; Pedigree; Physical Conditioning, Animal; Recurrence; Rhabdomyolysis | 2005 |
Weight restoration in a patient with anorexia nervosa on dialysis.
Topics: Adult; Anorexia Nervosa; Aspirin; Barbiturates; Body Mass Index; Body Weight; Caffeine; Combined Modality Therapy; Comorbidity; Cooperative Behavior; Creatinine; Drug Combinations; Female; Heart Failure; Humans; Kidney Failure, Chronic; Patient Care Team; Psychotherapy, Group; Recurrence; Renal Dialysis; Substance-Related Disorders; Treatment Outcome; Treatment Refusal; Water-Electrolyte Imbalance | 2005 |
Risks of repeated miscarriage.
Topics: Abortion, Spontaneous; Adult; Caffeine; Case-Control Studies; Cotinine; Dietary Supplements; Female; Fertilization; Folic Acid; Humans; Leiomyoma; Maternal Age; Pregnancy; Recurrence; Risk Factors; Smoking; Sweden; Uterine Neoplasms | 2006 |
Acute migraine treatment: patterns of use and satisfaction in a clinical population.
Topics: Acetaminophen; Acute Disease; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Caffeine; Drug Combinations; Ergotamine; Female; Health Surveys; Humans; Male; Middle Aged; Migraine Disorders; Narcotics; Nonprescription Drugs; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Surveys and Questionnaires | 2006 |
Analgesic abuse and the kidney.
Topics: Aged; Analgesics; Aspirin; Caffeine; Codeine; Drug Combinations; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Male; Nephrectomy; Nephritis, Interstitial; Oxycodone; Phenacetin; Pseudomonas Infections; Pyelonephritis; Recurrence; Substance-Related Disorders; Transplantation, Homologous | 1980 |
Spontaneous abortion in a hospital population: are tobacco and coffee intake risk factors?
Topics: Abortion, Spontaneous; Adult; Age Factors; Alcohol Drinking; Caffeine; Case-Control Studies; Coffee; Cohort Studies; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Female; Humans; Logistic Models; Marital Status; Menarche; Odds Ratio; Pregnancy; Recurrence; Reproductive History; Retrospective Studies; Risk Factors; Smoking | 1994 |
Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine.
Topics: Affective Disorders, Psychotic; Aged; Caffeine; Clozapine; Combined Modality Therapy; Depressive Disorder; Drug Therapy, Combination; Electrocardiography; Electroconvulsive Therapy; Female; Humans; Recurrence; Tachycardia, Supraventricular | 1994 |
Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Benzazepines; Caffeine; Cocaine; Dopamine Agonists; Ergolines; Male; Motor Activity; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Recurrence; Reinforcement, Psychology; Substance-Related Disorders; Tetrahydronaphthalenes | 1996 |
Limitations of acetaminophen, aspirin, and caffeine in alleviating migraine.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Caffeine; Drug Therapy, Combination; Humans; Migraine Disorders; Recurrence; Reproducibility of Results; Severity of Illness Index; Treatment Outcome | 1998 |
Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis.
Topics: Anesthetics, Inhalation; Animals; Biopsy; Caffeine; Central Nervous System Stimulants; Female; Halothane; Horse Diseases; Horses; Male; Malignant Hyperthermia; Membrane Potentials; Muscle Contraction; Muscle, Skeletal; Pedigree; Physical Exertion; Potassium; Recurrence; Regression Analysis; Rhabdomyolysis | 1999 |
Calcium regulation by skeletal muscle membranes of horses with recurrent exertional rhabdomyolysis.
Topics: Animals; Biopsy; Caffeine; Calcium; Calcium-Transporting ATPases; Dose-Response Relationship, Drug; Female; Horse Diseases; Horses; Male; Muscle, Skeletal; Physical Exertion; Recurrence; Rhabdomyolysis; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Scintillation Counting | 2000 |
Caffeine in the treatment of apnea associated with respiratory syncytial virus infection in neonates and infants.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Critical Care; Data Interpretation, Statistical; Follow-Up Studies; Humans; Infant; Infant, Newborn; Injections, Intravenous; Recurrence; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Time Factors | 2000 |
Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda.
Topics: Administration, Cutaneous; Adult; Caffeine; Case-Control Studies; Cytochrome P-450 CYP1A2; Estrogen Replacement Therapy; Female; Humans; Liver; Menopause; Middle Aged; Phlebotomy; Porphyria Cutanea Tarda; Recurrence; Risk Factors; Safety | 2000 |
Stress fracture of the foot secondary to osteoporosis: an atypical presentation.
Topics: Adult; Caffeine; Female; Foot Bones; Fractures, Stress; Humans; Osteoporosis; Recurrence | 2001 |
Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53.
Topics: Adenocarcinoma; Alleles; Apoptosis; Blotting, Western; Caffeine; Cell Survival; Combined Modality Therapy; Comet Assay; Disease-Free Survival; DNA Damage; Dose-Response Relationship, Radiation; G2 Phase; Genes, p53; Humans; Inhibitory Concentration 50; Male; Mitosis; Mutation; Nuclear Proteins; Phosphodiesterase Inhibitors; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Radiation Tolerance; Radiotherapy; Recurrence; Risk Factors; Salvage Therapy; Sarcoma; Sensitivity and Specificity; Time Factors; Tumor Cells, Cultured | 2001 |
Clinical features of withdrawal headache following overuse of triptans and other headache drugs.
Topics: Analgesics; Caffeine; Causality; Codeine; Drug Overdose; Headache; Headache Disorders; Humans; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 2002 |
The course of a seasonal bipolar disorder influenced by caffeine.
Topics: Bipolar Disorder; Caffeine; Chlorpromazine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Middle Aged; Recurrence; Seasons | 1991 |
Low-dose doxapram for apnoea of prematurity.
Topics: Apnea; Caffeine; Doxapram; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature, Diseases; Pilot Projects; Recurrence | 1986 |
[Cytolytic episodes during cirrhosis].
Topics: Antipyrine; Anxiety Disorders; Barbiturates; Caffeine; Cholestasis; Drug Therapy, Combination; Female; Haloperidol; Humans; Liver Cirrhosis; Maprotiline; Middle Aged; Recurrence; Temazepam; Time Factors | 1986 |
Biochemical validation of self-reported caffeine consumption during caffeine fading.
Topics: Adult; Caffeine; Coffee; Female; Humans; Male; Middle Aged; Recurrence; Self Disclosure; Substance-Related Disorders; Tea; Xanthines | 1988 |
Primary liquid intake and urinary stone disease.
Topics: Adolescent; Adult; Animals; Beer; Beverages; Caffeine; Cattle; Drinking; Epidemiologic Methods; Hernia, Inguinal; Humans; Male; Middle Aged; Milk; Recurrence; Risk; United States; Ureteral Calculi | 1985 |
Migraine headaches.
Topics: Caffeine; Contraceptives, Oral; Cyproheptadine; Diagnosis, Differential; Diuretics; Drug Combinations; Ergotamine; Humans; Methysergide; Migraine Disorders; Monoamine Oxidase Inhibitors; Personality; Propranolol; Recurrence; Stress, Physiological; Substance Withdrawal Syndrome; Tranquilizing Agents | 1972 |